Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.

Johanna Buchroithner, Friedrich Erhart, Josef Pichler, Georg Widhalm, Matthias Preusser, Günther Stockhammer, Martha Nowosielski, Sarah Iglseder, Christian F Freyschlag, Stefan Oberndorfer, Karin Bordihn, Gord von Campe, Markus Hoffermann, Reinhard Ruckser, Karl Rössler, Sabine Spiegl-Kreinecker, Michael B Fischer, Thomas Czech, Carmen Visus, Günther KrumplThomas Felzmann, Christine Marosi

Research output: Contribution to journalOriginal Article (Journal)peer-review

65 Citations (Web of Science)
Original languageEnglish
JournalCancers
Volume10
Issue number10
DOIs
Publication statusPublished - 2018

Keywords

  • SIPULEUCEL-T IMMUNOTHERAPY
  • PERIPHERAL LYMPHOID ORGANS
  • RESISTANT PROSTATE-CANCER
  • CENTRAL-NERVOUS-SYSTEM
  • MALIGNANT GLIOMA
  • CLINICAL-TRIAL
  • STEM-CELLS
  • STANDARD TREATMENT
  • MARKER CD133
  • OPEN-LABEL

Cite this